"Gefitinib" . "Autor uv\u00E1d\u00ED l\u00E9kov\u00E9 charakteristiky gefitinibu. Tento l\u00E9k je indikov\u00E1n u nemocn\u00FDch snemalobun\u011B\u010Dn\u00FDmi karcinomy plic smutacemi genu EGFR. Vp\u0159ehledu jsou uvedeny klinick\u00E9 studie dokl\u00E1daj\u00EDc\u00ED \u00FA\u010Dinnost a bezpe\u010Dnost prepar\u00E1tu."@cs . "CZ - \u010Cesk\u00E1 republika" . . . "2" . "4"^^ . . . "Author presented pharmacologic and pharmacokinetic properies of gefitinib. This drug is of value in non small cell lung cancer expressing EGFR gene mutations. In overview clinical studies concerning effectivity and tolerability of this drug are also presented."@en . "Gefitinib"@en . . . "RIV/00669806:_____/10:00300923!RIV11-MZ0-00669806" . "V" . . "[5C6EDFA53B48]" . "1"^^ . "1801-1209" . . "6" . "Gefitinib"@cs . "1"^^ . . . . "Gefitinib"@cs . "Farmakoterapie" . "Pe\u0161ek, Milo\u0161" . "Gefitinib; non small cell lung cancer; EGFR gene mutations"@en . "Autor uv\u00E1d\u00ED l\u00E9kov\u00E9 charakteristiky gefitinibu. Tento l\u00E9k je indikov\u00E1n u nemocn\u00FDch snemalobun\u011B\u010Dn\u00FDmi karcinomy plic smutacemi genu EGFR. Vp\u0159ehledu jsou uvedeny klinick\u00E9 studie dokl\u00E1daj\u00EDc\u00ED \u00FA\u010Dinnost a bezpe\u010Dnost prepar\u00E1tu." . . "260266" . . "Gefitinib" . "Gefitinib"@en . "RIV/00669806:_____/10:00300923" . .